XTX Topco Ltd Acquires 87,481 Shares of agilon health, inc. (NYSE:AGL)

XTX Topco Ltd boosted its holdings in shares of agilon health, inc. (NYSE:AGL) by 271.1% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 119,747 shares of the company’s stock after acquiring an additional 87,481 shares during the quarter. XTX Topco Ltd’s holdings in agilon health were worth $471,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in the business. Point72 Asia Singapore Pte. Ltd. acquired a new position in shares of agilon health in the 3rd quarter worth approximately $28,000. CWM LLC lifted its position in shares of agilon health by 406.5% in the 2nd quarter. CWM LLC now owns 9,081 shares of the company’s stock worth $59,000 after purchasing an additional 7,288 shares during the period. Nisa Investment Advisors LLC acquired a new position in shares of agilon health in the 2nd quarter worth approximately $60,000. Allspring Global Investments Holdings LLC lifted its position in shares of agilon health by 17,790.0% in the 2nd quarter. Allspring Global Investments Holdings LLC now owns 10,734 shares of the company’s stock worth $70,000 after purchasing an additional 10,674 shares during the period. Finally, Pallas Capital Advisors LLC acquired a new position in shares of agilon health during the 2nd quarter valued at $77,000.

Insider Buying and Selling at agilon health

In other news, Director John William Wulf acquired 45,000 shares of the business’s stock in a transaction dated Thursday, December 5th. The stock was bought at an average cost of $2.18 per share, for a total transaction of $98,100.00. Following the completion of the transaction, the director now owns 206,133 shares of the company’s stock, valued at $449,369.94. The trade was a 27.93 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, Director Karen Mcloughlin acquired 25,000 shares of the business’s stock in a transaction dated Friday, December 13th. The stock was purchased at an average price of $2.20 per share, with a total value of $55,000.00. Following the completion of the transaction, the director now directly owns 73,166 shares of the company’s stock, valued at $160,965.20. This trade represents a 51.90 % increase in their position. The disclosure for this purchase can be found here. Insiders have acquired a total of 90,000 shares of company stock valued at $198,100 over the last three months. 3.20% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on the stock. TD Cowen dropped their target price on shares of agilon health from $6.00 to $2.00 and set a “hold” rating on the stock in a research report on Monday, November 11th. Bank of America downgraded shares of agilon health from a “buy” rating to an “underperform” rating and set a $3.00 price objective on the stock. in a report on Wednesday, October 2nd. Royal Bank of Canada restated an “outperform” rating and set a $3.00 price objective on shares of agilon health in a report on Tuesday, November 19th. William Blair downgraded shares of agilon health from an “outperform” rating to a “market perform” rating in a report on Friday, November 8th. Finally, Stifel Nicolaus lowered their price objective on shares of agilon health from $7.00 to $2.00 and set a “hold” rating on the stock in a report on Tuesday, November 12th. Three research analysts have rated the stock with a sell rating, fifteen have issued a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat.com, agilon health currently has an average rating of “Hold” and an average price target of $4.38.

agilon health Price Performance

AGL opened at $2.24 on Friday. The firm has a market cap of $922.92 million, a P/E ratio of -2.38 and a beta of 0.51. The firm has a 50-day moving average of $2.44 and a 200 day moving average of $4.38. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.29 and a current ratio of 1.29. agilon health, inc. has a fifty-two week low of $1.50 and a fifty-two week high of $13.76.

agilon health (NYSE:AGL) last released its quarterly earnings data on Thursday, November 7th. The company reported ($0.29) EPS for the quarter, missing the consensus estimate of ($0.10) by ($0.19). The business had revenue of $1.45 billion for the quarter, compared to analysts’ expectations of $1.47 billion. agilon health had a negative net margin of 6.88% and a negative return on equity of 47.84%. During the same period last year, the company earned ($0.06) earnings per share. On average, research analysts expect that agilon health, inc. will post -0.52 EPS for the current year.

agilon health Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.